Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

sleep · Mechanism Report

Can ADRB2 rs1042713 and COMT rs4680 prolong arousal after an overnight fuel signal?

ADRB2 rs1042713 and COMT rs4680 may influence adrenergic signaling and catecholamine clearance in ways that can extend arousal after an overnight fuel deficit.

PlausibleJuly 20, 202624 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

ADRB2 rs1042713 and COMT rs4680 can influence adrenergic receptor signaling and catecholamine breakdown, which may amplify or prolong arousal after an overnight fuel signal.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes an overnight metabolic shift that triggers a catecholamine-driven counterregulatory response to restore glucose. It frames ADRB2 variation as altering receptor signaling and COMT variation as slowing catecholamine breakdown, which together could lengthen the arousal response. The mechanism graph connects these pathways to hepatic glycogenolysis, glucose release, and sleep-related awakening.

Verified conclusion

Overnight metabolic shifts trigger a physiological counterregulatory cascade that interacts with genetic variations in adrenergic receptor sensitivity and neurotransmitter clearance.

Genetic modulation of adrenergic signaling

  • ADRB2 rs1042713 (Arg16Gly): The Gly16 variant promotes heightened agonist-induced receptor desensitization and downregulation, directly modulating target-cell sensitivity to adrenergic stimulation.
  • COMT rs4680 (Val158Met): This polymorphism yields a 3- to 4-fold difference in enzymatic activity. Met/Met homozygotes possess a thermolabile enzyme that processes catecholamines slowly, resulting in sustained synaptic concentrations of norepinephrine and epinephrine compared to rapid-clearing Val/Val homozygotes.

Metabolic arousal and clearance mechanisms

  • Adrenergic Counterregulation: Nocturnal fuel deficits, such as falling blood glucose, initiate a robust sympathoadrenal response, triggering systemic epinephrine and norepinephrine release.
  • Glucose Mobilization: These catecholamines stimulate beta-adrenergic receptors and downstream cyclic adenosine monophosphate (cAMP) signaling to activate hepatic glycogenolysis, releasing glucose to restore systemic levels.
  • Prolonged Arousal: This adrenergic surge is tightly coupled to wakefulness, with epinephrine spikes consistently preceding EEG-defined arousal. Slower enzymatic degradation (via COMT Met alleles) combined with altered receptor dynamics (ADRB2) plausibly extends catecholamine availability, prolonging the physiological and cortical arousal initiated by the overnight metabolic rescue.

Bottom line

  • An overnight fuel deficit triggers a necessary adrenergic counterregulatory response to mobilize glucose via hepatic glycogenolysis; however, in individuals carrying the slower-clearing COMT rs4680 Met allele or altered ADRB2 rs1042713 variants, this survival mechanism can plausibly amplify and extend the duration of physiological sleep arousal.

References

  1. ADRB2 Polymorphisms (rs1042713 and rs1042714 ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  2. ADRB2 Gly16Arg polymorphism, asthma control and lung function decline — publications.ersnet.org ↗
  3. Childhood asthma exacerbations and the Arg-16 beta2 receptor polymorphism: a meta-analysis stratified by treatment — ncbi.nlm.nih.gov ↗
  4. Association of β2-adrenergic receptor gene polymorphisms (rs1042713, rs1042714, rs1042711) with asthma risk: a systematic review and updated meta-analysis - BMC Pulmonary Medicine — bmcpulmmed.biomedcentral.com ↗
  5. Effect of Beta 2-Adrenergic Receptor Gly16Arg Polymorphism on ... — pmc.ncbi.nlm.nih.gov ↗
  6. ADRB2 Arg16Gly Polymorphism and Pulmonary Function ... — pmc.ncbi.nlm.nih.gov ↗
  7. Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context — pmc.ncbi.nlm.nih.gov ↗
  8. Influence of ADRB1, ADRB2, and COMT Genetic Polymorphisms on Postoperative Outcomes of Patients Undergoing Cardiac Valve Surgery. — linkinghub.elsevier.com ↗
  9. Influence of ADRB1, ADRB2, and COMT Genetic ... — pubmed.ncbi.nlm.nih.gov ↗
  10. The role of the COMT val158met polymorphism in mediating ... — pmc.ncbi.nlm.nih.gov ↗
  11. Potential Impact of COMT-rs4680 G > A Gene Polymorphism ... — pmc.ncbi.nlm.nih.gov ↗
  12. Relations between catechol-O-methyltransferase Val158Met ... — pmc.ncbi.nlm.nih.gov ↗
  13. 1. Comt And The... — pmc.ncbi.nlm.nih.gov ↗
  14. The polymorphism Val158Met in the COMT gene - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  15. The Val158Met polymorphism of the COMT gene is ... — pmc.ncbi.nlm.nih.gov ↗
  16. Defective Awakening Response to Nocturnal Hypoglycemia in Patients with Type 1 Diabetes Mellitus — dx.plos.org ↗
  17. Hypoglycemia counterregulation during sleep — pubmed.ncbi.nlm.nih.gov ↗
  18. Defective Awakening Response to Nocturnal Hypoglycemia in Patients ... — pmc.ncbi.nlm.nih.gov ↗
  19. Awakening from Sleep and Hypoglycemia in Type 1 Diabetes Mellitus — pmc.ncbi.nlm.nih.gov ↗
  20. Awakening and Counterregulatory Response to Hypoglycemia During Early and Late Sleep — diabetesjournals.org ↗
  21. Sleep-Related Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes: Reduced Awakening From Sleep During Hypoglycemia — diabetesjournals.org ↗
  22. Connecting insufficient sleep and insomnia with metabolic dysfunction — pmc.ncbi.nlm.nih.gov ↗
  23. Glucocorticoids influence brain glycogen levels during sleep deprivation | American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | American Physiological Society — journals.physiology.org ↗
  24. Glycogen metabolism and the homeostatic regulation of sleep — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible7 sourcesDoes alcohol near bedtime worsen obstructive respiratory events?→Plausible8 sourcesCan nocturia, bruxism, sleep movements, insomnia, anxiety, and heavy caffeine use worsen sleep fragmentation in obstructive sleep apnea?→